Invitae Corporation
NVTAUnited States
34 filed reports · 486 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
34 reports · Jun 2015 to Sep 2023Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 26 | 4,075 | Jun 2015 to Sep 2023 |
| Annual · 10-KSEC EDGAR | 8 | 3,449 | Dec 2015 to Dec 2022 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2023 Q3 | 10-Q | 2023-09-30 | 2023-11-08 | 383 | Open |
| FY2023 Q2 | 10-Q | 2023-06-30 | 2023-08-08 | 247 | Open |
| FY2023 Q1 | 10-Q | 2023-03-31 | 2023-05-09 | 240 | Open |
| FY2022 | 10-K | 2022-12-31 | 2023-02-28 | 855 | Open |
| FY2022 Q3 | 10-Q | 2022-09-30 | 2022-11-08 | 143 | Open |
| FY2022 Q2 | 10-Q | 2022-06-30 | 2022-08-09 | 159 | Open |
| FY2022 Q1 | 10-Q | 2022-03-31 | 2022-05-03 | 136 | Open |
| FY2021 | 10-K | 2021-12-31 | 2022-03-01 | 437 | Open |
| FY2021 Q3 | 10-Q | 2021-09-30 | 2021-11-09 | 124 | Open |
| FY2021 Q2 | 10-Q | 2021-06-30 | 2021-08-09 | 132 | Open |
| FY2021 Q1 | 10-Q | 2021-03-31 | 2021-05-04 | 123 | Open |
| FY2020 | 10-K | 2020-12-31 | 2021-02-26 | 392 | Open |
Financial data
486 concepts · 7,524 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial483 concepts · 7,197 facts · Dec 2013 to Sep 2023
- Allocated share based compensation expense49 · Dec 2013 to Sep 2023
- Cash and cash equivalents at carrying value49 · Dec 2013 to Sep 2023
- Comprehensive income net of tax49 · Dec 2013 to Sep 2023
- Cost of revenue (US GAAP)49 · Dec 2013 to Sep 2023
- General and administrative expense (US GAAP)49 · Dec 2013 to Sep 2023
- Interest expense (US GAAP)49 · Dec 2013 to Sep 2023
- Net income loss49 · Dec 2013 to Sep 2023
- Operating income loss49 · Dec 2013 to Sep 2023
- Other nonoperating income expense49 · Dec 2013 to Sep 2023
- Research and development expense49 · Dec 2013 to Sep 2023
- Revenue49 · Dec 2013 to Sep 2023
- Selling and marketing expense (US GAAP)49 · Dec 2013 to Sep 2023
- Depreciation depletion and amortization47 · Dec 2013 to Sep 2023
- Increase decrease in accounts payable47 · Dec 2013 to Sep 2023
- Increase decrease in accrued liabilities and other operating liabilities47 · Dec 2013 to Sep 2023
- Increase decrease in other operating assets47 · Dec 2013 to Sep 2023
- Increase (Decrease) in Prepaid Expense and Other Current Assets47 · Dec 2013 to Sep 2023
- Payments to acquire property plant and equipment47 · Dec 2013 to Sep 2023
- Share based compensation47 · Dec 2013 to Sep 2023
- Stockholders equity (US GAAP)46 · Dec 2013 to Sep 2023
- Accounts payable current44 · Dec 2014 to Sep 2023
- Accrued liabilities current44 · Dec 2014 to Sep 2023
- Accumulated depreciation depletion and amortization property plant and equipment44 · Dec 2014 to Sep 2023
- Additional paid in capital44 · Dec 2014 to Sep 2023
Geography1 concept · 189 facts · Dec 2013 to Sep 2023
- Revenue189 · Dec 2013 to Sep 2023
Product2 concepts · 138 facts · Dec 2016 to Sep 2023
- Revenue132 · Dec 2016 to Sep 2023
- Test Revenue6 · Mar 2017 to Mar 2018
Segments
327 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis8 members · 132 facts
- Collaboration and Genome Network34 · Dec 2016 to Sep 2023
- Diagnostic Tests34 · Dec 2016 to Sep 2023
- Centralized15 · Dec 2018 to Sep 2022
- Data/services10 · Dec 2020 to Sep 2023
- Oncology10 · Dec 2020 to Sep 2023
- Rare diseases10 · Dec 2020 to Sep 2023
- Women's health10 · Dec 2020 to Sep 2023
- Decentralized9 · Dec 2020 to Sep 2022
Statement geographicalsrt:StatementGeographicalAxis6 members · 124 facts
- United States34 · Dec 2016 to Sep 2023
- Canada33 · Dec 2016 to Sep 2023
- Rest of World32 · Dec 2016 to Sep 2023
- United Kingdom13 · Dec 2020 to Sep 2023
- Germany10 · Dec 2020 to Dec 2022
- Rest of world2 · Mar 2021 to Mar 2022
Statement geographicalus-gaap:StatementGeographicalAxis5 members · 65 facts
- Canada19 · Dec 2013 to Mar 2018
- Rest of World18 · Dec 2013 to Mar 2018
- United States18 · Dec 2013 to Mar 2018
- Israel9 · Dec 2013 to Dec 2015
- Singapore1 · Sep 2015
Product or serviceus-gaap:ProductOrServiceAxis3 members · 6 facts
- Institutions2 · Mar 2017 to Mar 2018
- Patient - direct2 · Mar 2017 to Mar 2018
- Patient - insurance2 · Mar 2017 to Mar 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of Invitae Corporation (NVTA) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.